Food Irradiation Clinical Trials

• Whole Brain Irradiation in Primary CNS Lymphoma (PCNSL)
  ClinicalTrials.gov Identifier: NCT00153530 - Recruiting
  Primary Central Nervous System Lymphoma
  
• Prone Breast Irradiation for Pendulous Breasts
  ClinicalTrials.gov Identifier: NCT00181363 - Active, not recruiting
  Breast Cancer
  
• Combination Chemotherapy With or Without Total-Body Irradiation Followed By Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma
  ClinicalTrials.gov Identifier: NCT00559104 - Active, not recruiting
  Lymphoma
  
• Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases
  ClinicalTrials.gov Identifier: NCT00317785 - Active, not recruiting
  Leukemia; Lymphoma; Myelodysplastic Syndromes
  
• Study of Total Body Irradiation in Combination With Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation Followed By Cyclosporine and Mycophenolate Mofetil in High Risk-Patients With Human Immunodeficiency Virus-1
  ClinicalTrials.gov Identifier: NCT00010348 - Recruiting
  HIV Infections
  
• Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00275015 - Active, not recruiting
  Leukemia
  
• Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00534430 - Active, not recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Busulfan, Etoposide, and Total-Body Irradiation Followed by Autologous Stem Cell Transplant and Aldesleukin in Treating Patients With Acute Myeloid Leukemia in First Remission
  ClinicalTrials.gov Identifier: NCT00534469 - Active, not recruiting
  Leukemia
  
• Cyclophosphamide, Fludarabine, and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy, Autologous Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00096382 - Active, not recruiting
  Melanoma (Skin)
  
• Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00243009 - Active, not recruiting
  Kidney Cancer
  
• Pilot Study of Protein Profiling of the Human Epidermal Cells After Ultraviolet Irradiation
  ClinicalTrials.gov Identifier: NCT00397436 - Recruiting
  Proteomics
  
• Partial Breast Irradiation Using Accelerated Intensity Modulated Radiotherapy in Early Stage Breast Cancer After Breast-Conserving Surgery
  ClinicalTrials.gov Identifier: NCT00581529 - Active, not recruiting
  Breast Cancer
  
• Partial Breast Irradiation With Multi-Catheter Brachytherapy for pT1-2pN0 Breast Cancer After Breast Conserving Surgery
  ClinicalTrials.gov Identifier: NCT00392184 - Active, not recruiting
  Breast Cancer
  
• Combination Chemotherapy, Total-Body Irradiation, and Alemtuzumab in Treating Patients Undergoing an Autologous Stem Cell Transplant for Stage I, Stage II, Stage III, or Stage IV Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00276809 - Active, not recruiting
  Leukemia
  
• Fludarabine, Alemtuzumab, and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Donor White Blood Cell Infusion in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00416884 - Active, not recruiting
  Leukemia
  
• Optimized Intensity Modulated Irradiation for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00580983 - Enrolling by invitation
  Head and Neck Cancer
  
• A Phase II Evaluation of Docetaxel and Carboplatin Followed by Tumor Volume Directed Pelvic Irradiation
  ClinicalTrials.gov Identifier: NCT00285415 - Recruiting
  Advanced Endometrial Adenocarcinoma, Stage III A, B, C
  
• Mantle Irradiation for Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00165269 - Active, not recruiting
  Hodgkin's Disease
  
• RAPID: Randomized Trial of Accelerated Partial Breast Irradiation
  ClinicalTrials.gov Identifier: NCT00282035 - Recruiting
  Breast Cancer
  
• Duration of Androgen Blockade Combined With Pelvic Irradiation in Prostate Cancers
  ClinicalTrials.gov Identifier: NCT00223171 - Recruiting
  Prostate Cancer
  
• Partial Breast Irradiation With Interstitial High Dose Rate Brachytherapy
  ClinicalTrials.gov Identifier: NCT00499057 - Recruiting
  Breast Cancer
  
• Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00226746 - Recruiting
  Carcinoma, Pancreatic Ductal
  
• Rituximab to the Preparative Regimen of Etoposide and Total Body Irradiation in Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00427791 - Recruiting
  Leukemia
  
• PROFIT - Prostate Fractionated Irradiation Trial
  ClinicalTrials.gov Identifier: NCT00304759 - Recruiting
  Prostate Cancer
  
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed By Donor Bone Marrow Transplant in Treating Patients With Sickle Cell Anemia
  ClinicalTrials.gov Identifier: NCT00489281 - Recruiting
  Precancerous/Nonmalignant Condition
  
• Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00365287 - Active, not recruiting
  Breast Cancer; Kidney Cancer; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
  
• Fludarabine, Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation Followed By Donor Bone Marrow Transplant in Treating Patients With Severe Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00335608 - Recruiting
  Precancerous/Nonmalignant Condition
  
• Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant
  ClinicalTrials.gov Identifier: NCT00354419 - Recruiting
  Precancerous/Nonmalignant Condition
  
• Cyclophosphamide, Fludarabine, Total-Body Irradiation, and Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer or Other Disease
  ClinicalTrials.gov Identifier: NCT00388102 - Recruiting
  Leukemia; Lymphoma; Myelodysplastic Syndromes
  
• Study of Four Different Chemotherapy Regimens With or Without Total-Body Irradiation Followed by Umbilical Cord Blood Transplant in Treating Patients With Relapsed or Refractory Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00547196 - Recruiting
  Leukemia; Lymphoma; Myelodysplastic Syndromes
  
• Partial Breast Irradiation (PBI) for Selected Patients With Early Breast Cancer
  ClinicalTrials.gov Identifier: NCT00325598 - Recruiting
  Breast Neoplasms
  
• Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00185835 - Active, not recruiting
  Head and Neck Cancer; Carcinoma, Squamous Cell
  
• Alemtuzumab, Fludarabine, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disorders
  ClinicalTrials.gov Identifier: NCT00553098 - Recruiting
  Precancerous/Nonmalignant Condition
  
• A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies
  ClinicalTrials.gov Identifier: NCT00402714 - Recruiting
  Hematologic Malignancies
  
• Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Leukemia Following Total Body Irradiation and Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00510315 - Recruiting
  Leukemia; Leukemia Survivors
  
• Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers
  ClinicalTrials.gov Identifier: NCT00003572 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma
  
• Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation
  ClinicalTrials.gov Identifier: NCT00165425 - Recruiting
  Hodgkin's Disease
  
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Immunodeficiency or Noncancerous Inherited Disorders
  ClinicalTrials.gov Identifier: NCT00358657 - Recruiting
  Precancerous/Nonmalignant Condition
  
• Ready to Use Therapeutic Food in the Rehabilitation of Severely Malnourished Children.
  ClinicalTrials.gov Identifier: NCT00131417 - Active, not recruiting
  Malnutrition; Severe
  
• Amifostine for Head and Neck Irradiation in Lymphoma
  ClinicalTrials.gov Identifier: NCT00136474 - Active, not recruiting
  Lymphoma; Hodgkin''s Disease; Non-Hodgkin''s Lymphoma
  
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing an Umbilical Cord Blood Transplant for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00309842 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
  
• Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Progressive Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00242931 - Recruiting
  Prostate Cancer
  
• Phase III of Unilateral Neck Irradiation With Amifostine in Patients With SCC of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00206752 - Recruiting
  Squamous Cell Carcinoma of the Head and Neck
  
• Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy vs Fractionated Whole-Brain Radiotherapy Alone for Multiple Primary or Metastatic Brain Tumors
  ClinicalTrials.gov Identifier: NCT00004659 - Active, not recruiting
  Brain Neoplasms
  
• Study of Total Body Irradiation and Fludarabine Followed By Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation in Combination With Cyclosporine and Mycophenolate Mofetil in Patients With Inherited Disorders
  ClinicalTrials.gov Identifier: NCT00010361 - Active, not recruiting
  Metabolism, Inborn Errors; Granulomatous Disease, Chronic
  
• Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00425802 - Recruiting
  Leukemia; Lymphoma
  
• Phase II Study of Motexafin Gadolinium and Cranial Irradiation in Patients With Newly Diagnosed Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00022256 - Active, not recruiting
  adult glioblastoma multiforme
  
• Fast Food Study: Assessment of the Effects of Fast-Food on Inflammatory Markers
  ClinicalTrials.gov Identifier: NCT00233311 - Recruiting
  Heart Diseases; Diabetes; Obesity
  
• The Food Intake Phenotype: Assessing Eating Behavior and Food Preferences as Risk Factors for Obesity
  ClinicalTrials.gov Identifier: NCT00342732 - Recruiting
  Obesity
  
• Chemotherapy and Total-Body Irradiation Followed By Autologous Lymphocyte Infusion, Aldesleukin, and Autologous Stem Cell Transplant in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00335127 - Recruiting
  Melanoma (Skin); Non-Melanomatous Skin Cancer
  
• Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00165412 - Recruiting
  Breast Cancer; Hodgkin's Disease
  
• High-Dose Total-Body Irradiation, Cyclophosphamide, Antithymocyte Globulin, and Autologous Stem Cell Transplant or High-Dose Cyclophosphamide in Treating Patients With Severe Systemic Sclerosis
  ClinicalTrials.gov Identifier: NCT00545038 - Recruiting
  Precancerous/Nonmalignant Condition
  
• Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00002961 - Active, not recruiting
  recurrent childhood acute lymphoblastic leukemia; childhood acute lymphoblastic leukemia in remission
  
• Fludarabine and 400 CGY Total Body Irradiation for Recipients of HLA-Matched or Mis-Matched Family or Unrelated Donor Hematopoietic Stem Cell Transplants Who Have Rejected Their First Allogeneic Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00472329 - Recruiting
  Graft Failure
  
• Chemotherapy With or Without Total-Body Irradiation in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Myelodysplastic Syndromes or Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00322101 - Recruiting
  Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed By Umbilical Cord Blood Stem Cell Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer and Other Diseases
  ClinicalTrials.gov Identifier: NCT00343798 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
  
• Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients with Hematological Diseases
  ClinicalTrials.gov Identifier: NCT00056966 - Recruiting
  Hematologic Malignancy
  
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed By Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin, and Umbilical Cord Blood Transplant in Treating Patients With Refractory Hematologic Cancers or Other Diseases
  ClinicalTrials.gov Identifier: NCT00354172 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Fludarabine, Total-body Irradiation, Donor Peripheral Stem Cell Transplantation, and Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00005799 - Active, not recruiting
  Leukemia; Renal Cell Cancer; Lymphoma; Eye Cancer; Kidney Cancer
  
• Accelerated Partial Breast Irradiation for Early Breast Cancer
  ClinicalTrials.gov Identifier: NCT00418210 - Recruiting
  Breast Cancer
  
• Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00245037 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Pilot Study of Lucentis Combined With Proton Beam Irradiation in Treating Wet Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00517010 - Recruiting
  Age-Related Macular Degeneration
  
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed By an Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00305682 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Study to Evaluate the Efficacy of Rituximab in Combination with Low-Dose Radiotherapy in Patients with Relapsed Non-Hodgkin''s Lymphoma
  ClinicalTrials.gov Identifier: NCT00147953 - Recruiting
  Non-Hodgkin''s Lymphoma
  
• Anti-Human CD45 Monoclonal Antibodies in Patients with Advanced Leukemia Prior to Allogeneic Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00057005 - Recruiting
  Leukemia
  
• Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic Metastases
  ClinicalTrials.gov Identifier: NCT00465023 - Recruiting
  Hepatocellular Cancer; Cholangiocarcinoma; Hepatic Metastases
  
• Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases
  ClinicalTrials.gov Identifier: NCT00450983 - Recruiting
  Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes
  
• Phase II Poor Risk Diffuse Large B-Cell Lymphoma (DLBCL) of Total Lymphoid Irradiation (TLI) and Antithymocyte Globlulin (ATG) Followed by Matched Allogeneic Hematopoietic Transplantation as Consolidation to Autologous Hematopoietic Cell Transplantation (
  ClinicalTrials.gov Identifier: NCT00482053 - Recruiting
  Lymphoma, B-Cell
  
• An Observational Study of Childhood Food Allergy
  ClinicalTrials.gov Identifier: NCT00356174 - Recruiting
  Food Hypersensitivity; Peanut Hypersensitivity; Egg Hypersensitivity; Milk Hypersensitivity
  
• High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse
  ClinicalTrials.gov Identifier: NCT00002630 - Active, not recruiting
  stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Fludarabine and Total-Body Irradiation Followed By a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00397813 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Secondary Myelofibrosis
  
• High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002788 - Active, not recruiting
  stage III chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; refractory chronic lymphocytic leukemia; ...
  
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00255684 - Recruiting
  Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors
  ClinicalTrials.gov Identifier: NCT00060255 - Active, not recruiting
  Cancer
  
• Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00185744 - Recruiting
  Breast Cancer; Ductal Carcinoma; Ductal Carcinoma In Situ
  
• Radiation Therapy in Preventing Brain Metastases in Patients With Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00006344 - Active, not recruiting
  extensive stage small cell lung cancer; limited stage small cell lung cancer
  
• Development and Validation of the Food Acceptability Questionnaire
  ClinicalTrials.gov Identifier: NCT00412724 - Active, not recruiting
  Healthy
  
• Provision of Breakfast Food in Behavioral Weight Loss
  ClinicalTrials.gov Identifier: NCT00200239 - Active, not recruiting
  Obesity
  
• Fludarabine and Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Peripheral Stem Cell Transplant for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00268268 - Recruiting
  Chronic Myeloproliferative Disorders; Diamond-Blackfan Anemia; Fanconi Anemia; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Precancerous/Nonmalignant Condition
  
• Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003870 - Active, not recruiting
  adult acute lymphoblastic leukemia in remission; recurrent adult acute lymphoblastic leukemia; recurrent childhood acute lymphoblastic leukemia; ...
  
• Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum
  ClinicalTrials.gov Identifier: NCT00081224 - Active, not recruiting
  adenocarcinoma of the rectum; stage II rectal cancer; stage III rectal cancer
  
• Effect of Food Upon Pharmacokinetics of Single Oral Dose of AZD2171
  ClinicalTrials.gov Identifier: NCT00306891 - Active, not recruiting
  Cancer
  
• Effect of Food on Bioavailability of Modified Release Formulations of Imatinib
  ClinicalTrials.gov Identifier: NCT00420043 - Active, not recruiting
  Healthy
  
• Phase 1 Study of SK3530 to Investigate of the Effect of Food
  ClinicalTrials.gov Identifier: NCT00443625 - Active, not recruiting
  Erectile Dysfunction
  
• Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00005801 - Active, not recruiting
  adult acute differentiated monocytic leukemia (M5b); adult acute myeloblastic leukemia without maturation (M1); ...
  
• Evaluation of Excessive UV Irradiation on Skin Aging by Multiphoton Laser Imaging and Biophysical Methods
  ClinicalTrials.gov Identifier: NCT00372047 - Not yet recruiting
  Skin Aging
  
• Assessing the Presence of Casomorphins in Human Plasma After Dairy Ingestion
  ClinicalTrials.gov Identifier: NCT00360919 - Active, not recruiting
  Food Habits
  
• Teeth Dosimetry Determination
  ClinicalTrials.gov Identifier: NCT00178347 - Not yet recruiting
  Radiation Tolerance
  
• Effects of Divalproex Sodium on Food Intake, Energy Expenditure, and Posture Allocation
  ClinicalTrials.gov Identifier: NCT00287053 - Active, not recruiting
  Healthy
  
• Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00005866 - Active, not recruiting
  untreated adult acute myeloid leukemia; secondary myelodysplastic syndrome; de novo myelodysplastic syndrome; ...
  
• Total Body Irradiation, Thiotepa, and Fludarabine Followed By A Donor Peripheral Blood Stem Cell Transplant in Treating Young Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00112567 - Active, not recruiting
  childhood acute lymphoblastic leukemia; childhood acute myeloid leukemia and other myeloid malignancies; Chronic Myelogenous Leukemia; ...
  
• Neoadjuvant Cetuximab, Fluorouracil, and Pelvic Irradiation in Treating Patients With Locally Advanced or Locally Recurrent Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00084773 - Active, not recruiting
  recurrent rectal cancer; stage II rectal cancer; stage III rectal cancer; adenocarcinoma of the rectum
  
• Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00008151 - Active, not recruiting
  Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; recurrent adult acute myeloid leukemia; ...
  
• Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00044954 - Active, not recruiting
  Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm
  
• Chemotherapy, Low-Dose Total-Body Irradiation, and Peripheral Stem Cell Transplantation Followed By Chemotherapy and Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00003145 - Active, not recruiting
  chronic phase chronic myelogenous leukemia; accelerated phase chronic myelogenous leukemia; ...
  
• Prophylactic Irradiation to the Contralateral Breast for BRCA Mutation Carriers Undergoing Treatment for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00496288 - Not yet recruiting
  Breast Cancer
  
• Stem Cell Transplant for Patients with Hematologic Diseases and Renal Cell Cancer Using Family Donors and Conditioning with Campath-1H
  ClinicalTrials.gov Identifier: NCT00058825 - Recruiting
  Hematologic Malignancies
  
• Total-Body Irradiation Plus Chemotherapy Followed By Donor Bone Marrow Transplantation in Treating Children With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00028730 - Active, not recruiting
  acute leukemia; childhood large cell lymphoma; childhood lymphoblastic lymphoma; childhood small noncleaved cell lymphoma; chronic leukemia; ...
  
• Fludarabine and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00119340 - Active, not recruiting
  accelerated phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; relapsing chronic myelogenous leukemia; ...
  
• Cognitive Function and Cue-Reactivity Study
  ClinicalTrials.gov Identifier: NCT00194246 - Active, not recruiting
  Cognitive Performance; Food Cravings